803 related articles for article (PubMed ID: 9413680)
1. Specifications from a biotechnology industry perspective.
Garnick RL
Dev Biol Stand; 1997; 91():31-6. PubMed ID: 9413680
[TBL] [Abstract][Full Text] [Related]
2. Global perspective on specifications for biotechnology products--perspective from Japan.
Hayakawa T
Dev Biol Stand; 1997; 91():15-23. PubMed ID: 9413678
[No Abstract] [Full Text] [Related]
3. Development of specifications for biotechnology products--perspective from Europe.
Trouvin JH
Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679
[No Abstract] [Full Text] [Related]
4. FDA perspective on specifications for biotechnology products--from IND to PLA.
Murano G
Dev Biol Stand; 1997; 91():3-13. PubMed ID: 9413677
[TBL] [Abstract][Full Text] [Related]
5. Characterization and establishment of specifications for biopharmaceuticals.
Davis GC; Riggin RM
Dev Biol Stand; 1997; 91():49-54. PubMed ID: 9413683
[TBL] [Abstract][Full Text] [Related]
6. Raw material considerations.
Lubiniecki AS; Shadle PJ
Dev Biol Stand; 1997; 91():65-72. PubMed ID: 9413684
[TBL] [Abstract][Full Text] [Related]
7. The role of assay validation in specification development.
Baffi RA
Dev Biol Stand; 1997; 91():105-13. PubMed ID: 9413687
[TBL] [Abstract][Full Text] [Related]
8. In-process testing and limits.
Sjöholm I
Dev Biol Stand; 1997; 91():73-8. PubMed ID: 9413685
[No Abstract] [Full Text] [Related]
9. The use of bioassays for the characterisation and control of biological therapeutic products produced by biotechnology.
Thorpe R; Wadhwa M; Mire-Sluis A
Dev Biol Stand; 1997; 91():79-88. PubMed ID: 9413686
[TBL] [Abstract][Full Text] [Related]
10. Global regulatory considerations for unified assay specifications.
Patterson S; Lin L; Elchico J; Fuchs R; Powell S; Redhair D; Warwick M; Solli N; Méndez B
Dev Biol Stand; 1997; 91():45-8. PubMed ID: 9413682
[TBL] [Abstract][Full Text] [Related]
11. Roadmap for implementation of quality by design (QbD) for biotechnology products.
Rathore AS
Trends Biotechnol; 2009 Sep; 27(9):546-53. PubMed ID: 19647883
[TBL] [Abstract][Full Text] [Related]
12. Quality control and analytical techniques for biopharmaceuticals.
Robinson CJ; Jones C
Bioanalysis; 2011 Jan; 3(1):81-95. PubMed ID: 21175369
[TBL] [Abstract][Full Text] [Related]
13. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 1999; 885():i-vi, 1-156. PubMed ID: 10352573
[TBL] [Abstract][Full Text] [Related]
14. Appropriate specifications at the IND stage.
Geigert J
Dev Biol Stand; 1997; 91():39-43. PubMed ID: 9413681
[TBL] [Abstract][Full Text] [Related]
15. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organization
World Health Organ Tech Rep Ser; 2005; 929():1-142, backcover. PubMed ID: 16353684
[TBL] [Abstract][Full Text] [Related]
16. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 2003; 917():i-viii, 1-125, back cover. PubMed ID: 15024913
[TBL] [Abstract][Full Text] [Related]
17. Opportunities and challenges of real-time release testing in biopharmaceutical manufacturing.
Jiang M; Severson KA; Love JC; Madden H; Swann P; Zang L; Braatz RD
Biotechnol Bioeng; 2017 Nov; 114(11):2445-2456. PubMed ID: 28710854
[TBL] [Abstract][Full Text] [Related]
18. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
19. WHO expert committee on specifications for pharmaceutical preparations.
World Health Organization
World Health Organ Tech Rep Ser; 2013; (981):i-xi, 1-188. PubMed ID: 23821930
[TBL] [Abstract][Full Text] [Related]
20. WHO Expert Committee on Specifications for Pharmaceutical Preparations.
World Health Organ Tech Rep Ser; 2008; (948):1-138. PubMed ID: 18557474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
